Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Investigational

Italy

Participants:65+ years
Substances:Xevinapant

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Gen1046

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

Registered drugNo placebo

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Alemtuzumab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Early onset familial Alzheimer's disease

Not recruiting

Investigational

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Florquinitau (18F)

Contact Research Centre

Tourette's disorder

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ecopipam Hydrochloride

Contact Research Centre

Find therapies in clinical trials near you – page 291

3 617 trials match your criteria

Factor VIII deficiency+3

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Oesophageal carcinoma

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Facioscapulohumeral muscular dystrophy

Study on AOC 1020 for Adults with Facioscapulohumeral Muscular Dystrophy (FSHD)

Squamous cell carcinoma of head and neck

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Myelodysplastic syndrome

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Endometrial cancer

Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Hepatocellular carcinoma

Study on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer

B-cell type acute leukaemia

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Hepatocellular carcinoma

Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

Early onset familial Alzheimer's disease

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Tourette's disorder

Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.